Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pharmacogenomics ; 21(17): 1207-1215, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-33118445

RESUMO

Aim: This manuscript describes implementation of clinical decision support for providers concerned with perioperative complications of malignant hyperthermia susceptibility. Materials & methods: Clinical decision support for malignant hyperthermia susceptibility was implemented in 2018 based around our pre-emptive genotyping platform. We completed a brief descriptive review of patients who underwent pre-emptive testing, focused particularly on RYR1 and CACNA1S genes. Results: To date, we have completed pre-emptive genetic testing on more than 10,000 patients; 13 patients having been identified as a carrier of a pathogenic or likely pathogenic variant of RYR1 or CACNA1S. Conclusion: An alert system for malignant hyperthermia susceptibility - as an extension of our pre-emptive genomics platform - was implemented successfully. Implementation strategies and lessons learned are discussed herein.


Assuntos
Registros Eletrônicos de Saúde , Hipertermia Maligna/genética , Anestésicos Inalatórios/efeitos adversos , Canais de Cálcio Tipo L/genética , Sistemas de Apoio a Decisões Clínicas , Predisposição Genética para Doença , Testes Genéticos , Genótipo , Heterozigoto , Humanos , Hipertermia Maligna/epidemiologia , Hipertermia Maligna/fisiopatologia , Fármacos Neuromusculares Despolarizantes/efeitos adversos , Segurança do Paciente , Canal de Liberação de Cálcio do Receptor de Rianodina/genética , Succinilcolina/efeitos adversos
2.
G3 (Bethesda) ; 9(7): 2195-2198, 2019 07 09.
Artigo em Inglês | MEDLINE | ID: mdl-31064766

RESUMO

We have generated a single-copy knock-in loci for defined gene expression (SKI LODGE) system to insert any DNA by CRISPR/Cas9 at defined safe harbors in the Caenorhabditis elegans genome. Utilizing a single crRNA guide, which also acts as a Co-CRISPR enrichment marker, any DNA sequence can be introduced as a single copy, regulated by different tissue-specific promoters. The SKI LODGE system provides a fast, economical, and effective approach for generating single-copy ectopic transgenes in C. elegans.


Assuntos
Proteínas de Caenorhabditis elegans/genética , Caenorhabditis elegans/genética , Dosagem de Genes , Regulação da Expressão Gênica , Loci Gênicos , Animais , Sistemas CRISPR-Cas , Técnicas de Introdução de Genes , Marcação de Genes
3.
Curr Biol ; 24(22): 2622-31, 2014 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-25447994

RESUMO

BACKGROUND: In most cells, the cilium is formed within a compartment separated from the cytoplasm. Entry into the ciliary compartment is regulated by a specialized gate located at the base of the cilium in a region known as the transition zone. The transition zone is closely associated with multiple structures of the ciliary base, including the centriole, axoneme, and ciliary membrane. However, the contribution of these structures to the ciliary gate remains unclear. RESULTS: Here we report that, in Drosophila spermatids, a conserved module of transition zone proteins mutated in Meckel-Gruber syndrome (MKS), including Cep290, Mks1, B9d1, and B9d2, comprise a ciliary gate that continuously migrates away from the centriole to compartmentalize the growing axoneme tip. We show that Cep290 is essential for transition zone composition, compartmentalization of the axoneme tip, and axoneme integrity and find that MKS proteins also delimit a centriole-independent compartment in mouse spermatids. CONCLUSIONS: Our findings demonstrate that the ciliary gate can migrate away from the base of the cilium, thereby functioning independently of the centriole and of a static interaction with the axoneme to compartmentalize the site of axoneme assembly.


Assuntos
Axonema/metabolismo , Drosophila/citologia , Espermátides/metabolismo , Animais , Axonema/ultraestrutura , Cílios/metabolismo , Cílios/ultraestrutura , Drosophila/metabolismo , Proteínas de Drosophila/análise , Proteínas de Drosophila/metabolismo , Proteínas de Drosophila/fisiologia , Masculino , Camundongos , Proteínas Associadas aos Microtúbulos/análise , Proteínas Associadas aos Microtúbulos/metabolismo , Proteínas Associadas aos Microtúbulos/fisiologia , Espermátides/ultraestrutura
4.
Toxicol Pathol ; 35(7): 904-9, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18098037

RESUMO

Peroxisome proliferator-activated receptor gamma (PPARgamma) and dual PPARalpha and gamma agonists have been developed for use in the treatment of diabetes and hyperlipidemias. Vascular tumors were increased in mice treated with some PPAR agonists, but not in rats. Spontaneous hemangiosarcomas are common in several strains of mice, uncommon in rats, and rarely occur in humans. The objective of this study was to determine the endothelial cell proliferation rate in liver and adipose tissue of B6C3F1 mice, F344 rats, and humans to aid in investigations of the genesis and development of hemangiosarcoma formation, and to determine the relevance of the increased endothelial cell proliferation rate in drug-treated rodents in assessing the risk of these drugs in humans. We determined the endothelial cell labeling index (LI) in untreated mice, rats, and humans, in normal liver, brown fat (rats and mice only) and white fat by dual immunohistochemistry of CD31 and Ki-67. The LI, highest in mice and lowest in humans, was statistically significantly greater in the mouse compared to the human and rat. The increased rate of spontaneous or PPAR agonist-induced hemangiosarcoma formation in mice may be related to the higher background endothelial cell proliferation rate compared to rats and humans.


Assuntos
Tecido Adiposo/citologia , Células Endoteliais/citologia , Hemangiossarcoma/etiologia , Fígado/citologia , Adulto , Animais , Proliferação de Células , Feminino , Humanos , Masculino , Camundongos , Pessoa de Meia-Idade , PPAR gama/agonistas , Molécula-1 de Adesão Celular Endotelial a Plaquetas/análise , Ratos , Ratos Endogâmicos F344 , Especificidade da Espécie
5.
Toxicology ; 241(1-2): 58-65, 2007 Nov 20.
Artigo em Inglês | MEDLINE | ID: mdl-17897767

RESUMO

Cigarette smoking is the major environmental risk factor for bladder cancer in humans. Aromatic amines, potent DNA-reactive bladder carcinogens present in cigarette smoke, contribute significantly. However, increased cell proliferation, caused by direct mitogenesis or in response to cytotoxicity, may also play a role since urothelial hyperplasia has been observed in human cigarette smokers. We examined the urothelial effects of cigarette smoke (whole body inhalation exposure (Teague) system) in female C57BL/6 mice at various times in two studies, including reversibility evaluations. In both studies, no urothelial hyperplasia was observed by light microscopy in any group. However, in study 1, the Ki-67 labeling index (LI) of the urothelium was significantly increased in the smoke exposed group compared to controls through 3 months, but was not present at 6, 9 or 12 months even with continued exposures. In the groups that discontinued smoke exposure, it returned to the same levels as controls or lower. In study 2, the bromodeoxyuridine LI was similar to controls on day 1 but significantly increased at 5 days in the smoke exposed group. In the group that discontinued smoke exposure for 2 days, the LI was increased compared to controls but not significantly. Superficial urothelial cell cytotoxicity and necrosis were detectable by scanning electron microscopy at 5 days. Changes in LI of submucosal endothelial cells generally followed those of the urothelium and effects were reversible upon cessation of exposure. The increased urothelial proliferation appeared to be due to superficial cell cytotoxicity with consequent regeneration.


Assuntos
Células Endoteliais/patologia , Células Epiteliais/patologia , Fumar/patologia , Bexiga Urinária/patologia , Animais , Antimetabólitos , Bromodesoxiuridina , Sobrevivência Celular/efeitos dos fármacos , Feminino , Imuno-Histoquímica , Antígeno Ki-67/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Microscopia Eletrônica de Varredura , Mitógenos/toxicidade , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo
6.
Toxicol Pathol ; 35(3): 337-47, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17455081

RESUMO

Examination of the urine and the bladder epithelium are essential to the investigation of mechanisms of urinary bladder carcinogens in rodents. However, urine and bladder tissue specimens must be collected and processed properly if accurate data are to be derived. The optimum specimen for analysis of urinary constituents is fresh void urine collected from nonfasting animals. Fasting the animal prior to urine collection changes the normal composition, including pH. Many of the normal urinary constituents can influence the mode of action of bladder carcinogens, especially for non-genotoxic agents. Light microscopy is routinely used to examine the bladder epithelium. However, it is often necessary to use more sensitive techniques, such as scanning electron microscopy (SEM) to detect subtle cytotoxic changes in the superficial cell layer of the urothelium, and bromodeoxyuridine (BrdU) incorporation, PCNA, or Ki-67 immunohistochemistry to determine the labeling index for cell proliferation. The urinary bladder must be handled gently and inflated with fixative in situ before the animal dies to avoid artifactual autolytic damage to the bladder epithelium that is visible by SEM and may be mistaken for treatment-related changes. The purpose of this paper is to provide information for the proper collection and examination of urine and the urinary bladder.


Assuntos
Carcinógenos/toxicidade , Manejo de Espécimes/métodos , Neoplasias da Bexiga Urinária/patologia , Bexiga Urinária/patologia , Urina , Animais , Imuno-Histoquímica , Camundongos , Ratos , Bexiga Urinária/efeitos dos fármacos , Bexiga Urinária/ultraestrutura , Neoplasias da Bexiga Urinária/induzido quimicamente , Neoplasias da Bexiga Urinária/ultraestrutura , Urotélio/efeitos dos fármacos , Urotélio/patologia , Urotélio/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...